img

Global Oxytocin Injection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oxytocin Injection Market Insights, Forecast to 2034

Oxytocin injection is a synthetic form of oxytocin, a hormone that is naturally produced by the pituitary gland in the brain. Oxytocin is responsible for stimulating uterine contractions during labor and milk ejection during breastfeeding . Oxytocin injection is used to induce or augment labor, to control postpartum bleeding, or to terminate pregnancy . Oxytocin injection is administered intravenously or intramuscularly by a health care professional . According to the U.S. Food and Drug Administration, oxytocin injection is defined as “a sterile, clear, colorless aqueous solution of synthetic oxytocin, for intravenous infusion or intramuscular injection.
Global Oxytocin Injection market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Oxytocin Injection industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The industry trend of oxytocin injection is influenced by several factors, such as
The increasing demand for oxytocin injection in various regions of the world, especially in low- and middle-income countries where maternal mortality and morbidity are high due to complications of childbirth .
The growing awareness of the benefits and risks of oxytocin injection among consumers and health professionals, which encourages the appropriate use and regulation of oxytocin injection for different indications .
The advancement of technology and innovation that enable the improvement of oxytocin injection quality, safety, efficacy, and accessibility .
Some examples of the industry trend of oxytocin injection are
The emergence of new applications of oxytocin injection in different fields, such as psychiatry, neurology, and oncology .
The development of new formulations and delivery systems of oxytocin injection that enhance its stability, bioavailability, and convenience .
The introduction of new standards and guidelines that ensure the quality and safety of oxytocin injection in the global market .
Report Covers
This report presents an overview of global Oxytocin Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oxytocin Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


JHP Pharmaceuticals
Grindex
Pfizer
Novartis
GSK
Bimeda
Bayer
Agrilab
Kepro B.V.
Hybio Pharmaceutical
Shanghai Hefeng
Renjian Pharmaceutical
Segment by Type
Oxytocin
Carbetocin

Segment by Application


Animal Use
Human Use

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Oxytocin Injection plant distribution, commercial date of Oxytocin Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Oxytocin Injection introduction, etc. Oxytocin Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Oxytocin Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Oxytocin Injection Product Introduction
1.2 Market by Type
1.2.1 Global Oxytocin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oxytocin
1.2.3 Carbetocin
1.3 Market by Application
1.3.1 Global Oxytocin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Animal Use
1.3.3 Human Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Oxytocin Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Oxytocin Injection Revenue by Region
2.2.1 Global Oxytocin Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Oxytocin Injection Revenue by Region (2018-2024)
2.2.3 Global Oxytocin Injection Revenue by Region (2024-2029)
2.2.4 Global Oxytocin Injection Revenue Market Share by Region (2018-2029)
2.3 Global Oxytocin Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Oxytocin Injection Sales by Region
2.4.1 Global Oxytocin Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Oxytocin Injection Sales by Region (2018-2024)
2.4.3 Global Oxytocin Injection Sales by Region (2024-2029)
2.4.4 Global Oxytocin Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Oxytocin Injection Sales by Manufacturers
3.1.1 Global Oxytocin Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Oxytocin Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxytocin Injection in 2022
3.2 Global Oxytocin Injection Revenue by Manufacturers
3.2.1 Global Oxytocin Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Oxytocin Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Oxytocin Injection Revenue in 2022
3.3 Global Key Players of Oxytocin Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Oxytocin Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Oxytocin Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Oxytocin Injection, Product Offered and Application
3.8 Global Key Manufacturers of Oxytocin Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxytocin Injection Sales by Type
4.1.1 Global Oxytocin Injection Historical Sales by Type (2018-2024)
4.1.2 Global Oxytocin Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Oxytocin Injection Sales Market Share by Type (2018-2029)
4.2 Global Oxytocin Injection Revenue by Type
4.2.1 Global Oxytocin Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Oxytocin Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Oxytocin Injection Revenue Market Share by Type (2018-2029)
4.3 Global Oxytocin Injection Price by Type
4.3.1 Global Oxytocin Injection Price by Type (2018-2024)
4.3.2 Global Oxytocin Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Oxytocin Injection Sales by Application
5.1.1 Global Oxytocin Injection Historical Sales by Application (2018-2024)
5.1.2 Global Oxytocin Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Oxytocin Injection Sales Market Share by Application (2018-2029)
5.2 Global Oxytocin Injection Revenue by Application
5.2.1 Global Oxytocin Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Oxytocin Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Oxytocin Injection Revenue Market Share by Application (2018-2029)
5.3 Global Oxytocin Injection Price by Application
5.3.1 Global Oxytocin Injection Price by Application (2018-2024)
5.3.2 Global Oxytocin Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Oxytocin Injection Market Size by Type
6.1.1 US & Canada Oxytocin Injection Sales by Type (2018-2029)
6.1.2 US & Canada Oxytocin Injection Revenue by Type (2018-2029)
6.2 US & Canada Oxytocin Injection Market Size by Application
6.2.1 US & Canada Oxytocin Injection Sales by Application (2018-2029)
6.2.2 US & Canada Oxytocin Injection Revenue by Application (2018-2029)
6.3 US & Canada Oxytocin Injection Market Size by Country
6.3.1 US & Canada Oxytocin Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Oxytocin Injection Sales by Country (2018-2029)
6.3.3 US & Canada Oxytocin Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Oxytocin Injection Market Size by Type
7.1.1 Europe Oxytocin Injection Sales by Type (2018-2029)
7.1.2 Europe Oxytocin Injection Revenue by Type (2018-2029)
7.2 Europe Oxytocin Injection Market Size by Application
7.2.1 Europe Oxytocin Injection Sales by Application (2018-2029)
7.2.2 Europe Oxytocin Injection Revenue by Application (2018-2029)
7.3 Europe Oxytocin Injection Market Size by Country
7.3.1 Europe Oxytocin Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Oxytocin Injection Sales by Country (2018-2029)
7.3.3 Europe Oxytocin Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Oxytocin Injection Market Size
8.1.1 China Oxytocin Injection Sales (2018-2029)
8.1.2 China Oxytocin Injection Revenue (2018-2029)
8.2 China Oxytocin Injection Market Size by Application
8.2.1 China Oxytocin Injection Sales by Application (2018-2029)
8.2.2 China Oxytocin Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oxytocin Injection Market Size by Type
9.1.1 Asia Oxytocin Injection Sales by Type (2018-2029)
9.1.2 Asia Oxytocin Injection Revenue by Type (2018-2029)
9.2 Asia Oxytocin Injection Market Size by Application
9.2.1 Asia Oxytocin Injection Sales by Application (2018-2029)
9.2.2 Asia Oxytocin Injection Revenue by Application (2018-2029)
9.3 Asia Oxytocin Injection Sales by Region
9.3.1 Asia Oxytocin Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Oxytocin Injection Revenue by Region (2018-2029)
9.3.3 Asia Oxytocin Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Oxytocin Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Oxytocin Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Oxytocin Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Oxytocin Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Oxytocin Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Oxytocin Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Oxytocin Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Oxytocin Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Oxytocin Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Oxytocin Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 JHP Pharmaceuticals
11.1.1 JHP Pharmaceuticals Company Information
11.1.2 JHP Pharmaceuticals Overview
11.1.3 JHP Pharmaceuticals Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 JHP Pharmaceuticals Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 JHP Pharmaceuticals Recent Developments
11.2 Grindex
11.2.1 Grindex Company Information
11.2.2 Grindex Overview
11.2.3 Grindex Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Grindex Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grindex Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Overview
11.4.3 Novartis Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Overview
11.5.3 GSK Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 GSK Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 Bimeda
11.6.1 Bimeda Company Information
11.6.2 Bimeda Overview
11.6.3 Bimeda Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bimeda Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bimeda Recent Developments
11.7 Bayer
11.7.1 Bayer Company Information
11.7.2 Bayer Overview
11.7.3 Bayer Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Bayer Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Agrilab
11.8.1 Agrilab Company Information
11.8.2 Agrilab Overview
11.8.3 Agrilab Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Agrilab Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Agrilab Recent Developments
11.9 Kepro B.V.
11.9.1 Kepro B.V. Company Information
11.9.2 Kepro B.V. Overview
11.9.3 Kepro B.V. Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Kepro B.V. Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kepro B.V. Recent Developments
11.10 Hybio Pharmaceutical
11.10.1 Hybio Pharmaceutical Company Information
11.10.2 Hybio Pharmaceutical Overview
11.10.3 Hybio Pharmaceutical Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Hybio Pharmaceutical Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hybio Pharmaceutical Recent Developments
11.11 Shanghai Hefeng
11.11.1 Shanghai Hefeng Company Information
11.11.2 Shanghai Hefeng Overview
11.11.3 Shanghai Hefeng Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Shanghai Hefeng Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Hefeng Recent Developments
11.12 Renjian Pharmaceutical
11.12.1 Renjian Pharmaceutical Company Information
11.12.2 Renjian Pharmaceutical Overview
11.12.3 Renjian Pharmaceutical Oxytocin Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Renjian Pharmaceutical Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Renjian Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxytocin Injection Industry Chain Analysis
12.2 Oxytocin Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxytocin Injection Production Mode & Process
12.4 Oxytocin Injection Sales and Marketing
12.4.1 Oxytocin Injection Sales Channels
12.4.2 Oxytocin Injection Distributors
12.5 Oxytocin Injection Customers
13 Market Dynamics
13.1 Oxytocin Injection Industry Trends
13.2 Oxytocin Injection Market Drivers
13.3 Oxytocin Injection Market Challenges
13.4 Oxytocin Injection Market Restraints
14 Key Findings in The Global Oxytocin Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Oxytocin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oxytocin
Table 3. Major Manufacturers of Carbetocin
Table 4. Global Oxytocin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Oxytocin Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Oxytocin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Oxytocin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Oxytocin Injection Revenue Market Share by Region (2018-2024)
Table 9. Global Oxytocin Injection Revenue Market Share by Region (2024-2029)
Table 10. Global Oxytocin Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Oxytocin Injection Sales by Region (2018-2024) & (K Units)
Table 12. Global Oxytocin Injection Sales by Region (2024-2029) & (K Units)
Table 13. Global Oxytocin Injection Sales Market Share by Region (2018-2024)
Table 14. Global Oxytocin Injection Sales Market Share by Region (2024-2029)
Table 15. Global Oxytocin Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Oxytocin Injection Sales Share by Manufacturers (2018-2024)
Table 17. Global Oxytocin Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Oxytocin Injection Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Oxytocin Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Oxytocin Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Oxytocin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oxytocin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxytocin Injection as of 2022)
Table 23. Global Key Manufacturers of Oxytocin Injection, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oxytocin Injection, Product Offered and Application
Table 25. Global Key Manufacturers of Oxytocin Injection, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 28. Global Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 29. Global Oxytocin Injection Sales Share by Type (2018-2024)
Table 30. Global Oxytocin Injection Sales Share by Type (2024-2029)
Table 31. Global Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Oxytocin Injection Revenue Share by Type (2018-2024)
Table 34. Global Oxytocin Injection Revenue Share by Type (2024-2029)
Table 35. Oxytocin Injection Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Oxytocin Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 38. Global Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 39. Global Oxytocin Injection Sales Share by Application (2018-2024)
Table 40. Global Oxytocin Injection Sales Share by Application (2024-2029)
Table 41. Global Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Oxytocin Injection Revenue Share by Application (2018-2024)
Table 44. Global Oxytocin Injection Revenue Share by Application (2024-2029)
Table 45. Oxytocin Injection Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Oxytocin Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Oxytocin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Oxytocin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Oxytocin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Oxytocin Injection Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Oxytocin Injection Sales by Country (2024-2029) & (K Units)
Table 60. Europe Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 61. Europe Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 62. Europe Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 65. Europe Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 66. Europe Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Oxytocin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Oxytocin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Oxytocin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Oxytocin Injection Sales by Country (2018-2024) & (K Units)
Table 72. Europe Oxytocin Injection Sales by Country (2024-2029) & (K Units)
Table 73. China Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 74. China Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 75. China Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 78. China Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 79. China Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 82. Asia Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 83. Asia Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 86. Asia Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 87. Asia Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Oxytocin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Oxytocin Injection Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Oxytocin Injection Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Oxytocin Injection Sales by Region (2018-2024) & (K Units)
Table 93. Asia Oxytocin Injection Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Oxytocin Injection Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Oxytocin Injection Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Oxytocin Injection Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Oxytocin Injection Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oxytocin Injection Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Oxytocin Injection Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Oxytocin Injection Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Oxytocin Injection Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oxytocin Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Oxytocin Injection Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oxytocin Injection Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oxytocin Injection Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Oxytocin Injection Sales by Country (2024-2029) & (K Units)
Table 107. JHP Pharmaceuticals Company Information
Table 108. JHP Pharmaceuticals Description and Major Businesses
Table 109. JHP Pharmaceuticals Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. JHP Pharmaceuticals Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. JHP Pharmaceuticals Recent Developments
Table 112. Grindex Company Information
Table 113. Grindex Description and Major Businesses
Table 114. Grindex Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Grindex Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grindex Recent Developments
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Novartis Company Information
Table 123. Novartis Description and Major Businesses
Table 124. Novartis Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Novartis Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Novartis Recent Developments
Table 127. GSK Company Information
Table 128. GSK Description and Major Businesses
Table 129. GSK Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. GSK Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GSK Recent Developments
Table 132. Bimeda Company Information
Table 133. Bimeda Description and Major Businesses
Table 134. Bimeda Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bimeda Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bimeda Recent Developments
Table 137. Bayer Company Information
Table 138. Bayer Description and Major Businesses
Table 139. Bayer Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Bayer Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bayer Recent Developments
Table 142. Agrilab Company Information
Table 143. Agrilab Description and Major Businesses
Table 144. Agrilab Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Agrilab Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Agrilab Recent Developments
Table 147. Kepro B.V. Company Information
Table 148. Kepro B.V. Description and Major Businesses
Table 149. Kepro B.V. Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Kepro B.V. Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Kepro B.V. Recent Developments
Table 152. Hybio Pharmaceutical Company Information
Table 153. Hybio Pharmaceutical Description and Major Businesses
Table 154. Hybio Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Hybio Pharmaceutical Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Hybio Pharmaceutical Recent Developments
Table 157. Shanghai Hefeng Company Information
Table 158. Shanghai Hefeng Description and Major Businesses
Table 159. Shanghai Hefeng Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Shanghai Hefeng Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Shanghai Hefeng Recent Developments
Table 162. Renjian Pharmaceutical Company Information
Table 163. Renjian Pharmaceutical Description and Major Businesses
Table 164. Renjian Pharmaceutical Oxytocin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Renjian Pharmaceutical Oxytocin Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Renjian Pharmaceutical Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Oxytocin Injection Distributors List
Table 170. Oxytocin Injection Customers List
Table 171. Oxytocin Injection Market Trends
Table 172. Oxytocin Injection Market Drivers
Table 173. Oxytocin Injection Market Challenges
Table 174. Oxytocin Injection Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxytocin Injection Product Picture
Figure 2. Global Oxytocin Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oxytocin Injection Market Share by Type in 2022 & 2029
Figure 4. Oxytocin Product Picture
Figure 5. Carbetocin Product Picture
Figure 6. Global Oxytocin Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Oxytocin Injection Market Share by Application in 2022 & 2029
Figure 8. Animal Use
Figure 9. Human Use
Figure 10. Oxytocin Injection Report Years Considered
Figure 11. Global Oxytocin Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Oxytocin Injection Revenue 2018-2029 (US$ Million)
Figure 13. Global Oxytocin Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Oxytocin Injection Revenue Market Share by Region (2018-2029)
Figure 15. Global Oxytocin Injection Sales 2018-2029 ((K Units)
Figure 16. Global Oxytocin Injection Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Oxytocin Injection Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Oxytocin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Oxytocin Injection Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Oxytocin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Oxytocin Injection Sales YoY (2018-2029) & (K Units)
Figure 22. China Oxytocin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Oxytocin Injection Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Oxytocin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Oxytocin Injection Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Oxytocin Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Oxytocin Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Oxytocin Injection in the World: Market Share by Oxytocin Injection Revenue in 2022
Figure 29. Global Oxytocin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 31. Global Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 32. Global Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 33. Global Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Oxytocin Injection Revenue Share by Country (2018-2029)
Figure 39. US & Canada Oxytocin Injection Sales Share by Country (2018-2029)
Figure 40. U.S. Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 43. Europe Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 44. Europe Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 45. Europe Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 46. Europe Oxytocin Injection Revenue Share by Country (2018-2029)
Figure 47. Europe Oxytocin Injection Sales Share by Country (2018-2029)
Figure 48. Germany Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 49. France Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 53. China Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 54. China Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 55. China Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 56. China Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 57. Asia Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 58. Asia Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 59. Asia Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 60. Asia Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 61. Asia Oxytocin Injection Revenue Share by Region (2018-2029)
Figure 62. Asia Oxytocin Injection Sales Share by Region (2018-2029)
Figure 63. Japan Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 67. India Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Oxytocin Injection Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Oxytocin Injection Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Oxytocin Injection Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Oxytocin Injection Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Oxytocin Injection Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Oxytocin Injection Sales Share by Country (2018-2029)
Figure 74. Brazil Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Oxytocin Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Oxytocin Injection Value Chain
Figure 80. Oxytocin Injection Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries